JIC
RVLP

Joel Isaacson & Co’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Joel Isaacson & Co’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-45,006
Closed -$303K – 233
2020
Q2 		$303K Buy
+45,006
New +$220K 0.04% 161

Other funds holding RVLP

DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Joel Isaacson & Co's RVLP Position: Q3 2020 in Review

Joel Isaacson & Co sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2020, closing a stake of 45,006 shares — an estimated $303K sold.

Joel Isaacson & Co first reported a position in RVLP in Q2 2020 and held it in 1 quarter. The position peaked at $303K in Q2 2020. 62 funds tracked by Wall St. Rank hold RVLP as of Q3 2020.

  • Joel Isaacson & Co reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Joel Isaacson & Co sold 45,006 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2020, an estimated $303K.
  • Joel Isaacson & Co first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 1 quarter.
  • Joel Isaacson & Co's RVL Pharmaceuticals plc Ordinary Shares position peaked at $303K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2020.

Based on Joel Isaacson & Co's 13F filing for Q3 2020, filed 14 Oct 2020.